• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: September 5-9, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

September 5-9, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs9/7/11New York, NYN/AMarc Tessier-Lavigne (Rockefeller University)FDA and Regulatory Science
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs9/8/11New York, NYN/AN/AKeynote: Reducing Risk through Effective Policy and Public Health Practice
John M. Taylor, III, J.D., Counselor to the Commissioner9/5/11-9/9/11 N/AN/A N/ANo Significant Meetings
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy9/6/11Silver Spring, MDDara Corrigan, David Elder, Domenic Veneziano, Roberta WagnerCheryl Becker (DHL); Robby Beau, Andy Shiles, Tom Parker (FedEx); Don Woods (UPS); Mike Mullen (Express Association of America)FDA's Oversight of Import Entries Involving Express Courier Operations
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs9/5/11-9/9/11 N/AN/AN/ANo Significant Meetings
Lawrence R. Deyton, MSPH, MD, Director, Center for Tobacco Products9/5/11-9/9/11N/AN/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs9/5/11-9/9/11 N/AN/AN/ANo Significant Meetings
Elizabeth H. Dickinson, Esq., Acting Chief Counsel9/5/11-9/9/11 N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Associate Commissioner for Policy and Planning9/5/11-9/9/11 N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine9/5/11-9/9/11 N/AN/AN/ANo Significant Meetings
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health9/5/11-9/9/11 N/AN/AN/ANo Significant Meetings
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition9/5/11-9/9/11 N/AN/AN/ANo Significant Meetings
Caroline Lewis, Associate Commissioner for Operations9/5/11-9/9/11 N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research9/5/11-9/9/11 N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health9/5/11-9/9/11 N/AN/AN/ANo Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research9/6/11Little Rock, ARN/ADaniel Rahn (University of Arkansas for Medical Sciences)Implementation of MOU between FDA and the State of Arkansas
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods9/5/11-9/9/11 N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs9/5/11-9/9/11 N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research9/8/11Rockville, MDScott Furness, Larry OuderkirkRoger Williams, Matthew Van Hook (U.S. Pharmacopeia)Over the Counter Drug Substances and Products